Vincent S. Madison

Person

Ukiah, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Factor IXa crystals, related complexes and methods
- Patent number 8,710,188
- Issue date Apr 29, 2014
- Merck Sharp & Dohme Corp.
- Brian M. Beyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase i...
- Patent number 8,673,924
- Issue date Mar 18, 2014
- Merck Sharp & Dohme Corp.
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that are ERK inhibitors
- Patent number 8,546,404
- Issue date Oct 1, 2013
- Merck Sharp & Dohme
- Alan B. Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MEK1 polypeptides
- Patent number 8,440,443
- Issue date May 14, 2013
- Merck Sharp & Dohme Corp.
- Thierry O. Fischmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase domain polypeptide of human protein kinase B gamma (AKT3)
- Patent number 8,088,611
- Issue date Jan 3, 2012
- Schering Corp.
- Andrew J. Prongay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal of pregnane X receptor fused to steroid receptor coactivator-1
- Patent number 8,048,663
- Issue date Nov 1, 2011
- Schering Corp.
- Wenyan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding soluble, stable forms of human double minu...
- Patent number 8,034,907
- Issue date Oct 11, 2011
- Schering Corp.
- Shahriar Shane Taremi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor IXa crystals, related complexes and methods
- Patent number 7,968,683
- Issue date Jun 28, 2011
- Schering Corporation
- Brian M. Beyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HDM2 polypeptides
- Patent number 7,888,474
- Issue date Feb 15, 2011
- Schering Corporation
- Thomas E. Hesson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,879,890
- Issue date Feb 1, 2011
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for crystallizing aurora 2 kinase catalytic domain polypeptide
- Patent number 7,824,491
- Issue date Nov 2, 2010
- Schering Corp.
- Thierry O. Fischmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds that are ERK inhibitors
- Patent number 7,807,672
- Issue date Oct 5, 2010
- Schering Corporation
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Patent number 7,807,683
- Issue date Oct 5, 2010
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pregnane X receptor compositions, crystals and uses thereof
- Patent number 7,785,879
- Issue date Aug 31, 2010
- Schering Corporation
- Wenyan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding polypeptide fragments of protein kinase B...
- Patent number 7,776,589
- Issue date Aug 17, 2010
- Schering Corporation
- Andrew J. Prongay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HDM2 Polypeptides
- Patent number 7,705,127
- Issue date Apr 27, 2010
- Schering Corporation
- Thomas E. Hesson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]p...
- Patent number 7,700,773
- Issue date Apr 20, 2010
- Schering Corporation
- Alan K. Mallams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,687,527
- Issue date Mar 30, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,683,085
- Issue date Mar 23, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,638,513
- Issue date Dec 29, 2009
- Schering Corporation
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Soluble, stable form of HDM2, crystalline forms thereof and methods...
- Patent number 7,632,920
- Issue date Dec 15, 2009
- Schering Corporation
- Shahriar Shane Taremi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders and microbial...
- Patent number 7,553,864
- Issue date Jun 30, 2009
- Schering Corporation
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinas...
- Patent number 7,514,442
- Issue date Apr 7, 2009
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity quinoline-based kinase ligands
- Patent number 7,511,063
- Issue date Mar 31, 2009
- Schering Corporation
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,504,424
- Issue date Mar 17, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,488,745
- Issue date Feb 10, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,482,370
- Issue date Jan 27, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus NS3 helicase subdomain I
- Patent number 7,459,296
- Issue date Dec 2, 2008
- Schering Corporation
- Patricia C. Weber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Crystalline form of the catalytic domain of Aurora 2 kinase and met...
- Patent number 7,422,885
- Issue date Sep 9, 2008
- Schering Corporation
- Thierry O. Fischmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Catalytic domain of ADAM33 and methods of use thereof
- Patent number 7,335,758
- Issue date Feb 26, 2008
- Schering Corporation
- Wenyan Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Factor IXa Crystals, Related Complexes and Methods
- Publication number 20130157281
- Publication date Jun 20, 2013
- Schering Corporation
- BRIAN M. BEYER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Pregnane X Receptor Compositions, Crystals and Uses Thereof
- Publication number 20100286372
- Publication date Nov 11, 2010
- Schering Corporation
- Wenyan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HDM2 POLYPEPTIDES
- Publication number 20100267150
- Publication date Oct 21, 2010
- Schering Corporation
- THOMAS E. HESSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT3 POLYPEPTIDES
- Publication number 20100267053
- Publication date Oct 21, 2010
- Schering Corporation
- ANDREW J. PRONGAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1...
- Publication number 20100143384
- Publication date Jun 10, 2010
- Alan K. Mallams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1...
- Publication number 20100137326
- Publication date Jun 3, 2010
- Schering Corporation
- Alan K. Mallams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBLE, STABLE FORM OF HDM2, CRYSTALLINE FORMS THEREOF AND METHODS...
- Publication number 20100136620
- Publication date Jun 3, 2010
- Schering Corp.
- Shahriar Shane Taremi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE
- Publication number 20100074867
- Publication date Mar 25, 2010
- Schering Corporation Patent Department, K-6-1; 1990
- Srikanth Venkatraman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090170875
- Publication date Jul 2, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090137586
- Publication date May 28, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20090118284
- Publication date May 7, 2009
- Alan B. Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090111803
- Publication date Apr 30, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF THE CATALYTIC DOMAIN OF AURORA 2 KINASE AND MET...
- Publication number 20090081706
- Publication date Mar 26, 2009
- Schering Corporation
- Thierry O. Fischmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF
- Publication number 20080199447
- Publication date Aug 21, 2008
- Schering Corporation
- Wenyan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Publication number 20080050384
- Publication date Feb 28, 2008
- Shering Corporation and Pharmacopeia, Inc.
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel high affinity quinoline-based kinase ligands
- Publication number 20080045568
- Publication date Feb 21, 2008
- Schering Corporation
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20070232610
- Publication date Oct 4, 2007
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20070219218
- Publication date Sep 20, 2007
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20070191604
- Publication date Aug 16, 2007
- Alan Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders and microbial...
- Publication number 20070167426
- Publication date Jul 19, 2007
- Schering Corporation
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders and microbial...
- Publication number 20070129378
- Publication date Jun 7, 2007
- Schering Corporation
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1...
- Publication number 20070066621
- Publication date Mar 22, 2007
- Alan K. Mallams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Publication number 20070054925
- Publication date Mar 8, 2007
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Publication number 20070054906
- Publication date Mar 8, 2007
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Publication number 20070037824
- Publication date Feb 15, 2007
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Catalytic domain of ADAM33 and methods of use thereof
- Publication number 20070031401
- Publication date Feb 8, 2007
- Wenyan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060276506
- Publication date Dec 7, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for inhibiting KSP kinesin activity
- Publication number 20060247320
- Publication date Nov 2, 2006
- Schering Corporation
- Jayaram R. Tagat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060205797
- Publication date Sep 14, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
- Publication number 20060178371
- Publication date Aug 10, 2006
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY

Vincent S. Madison

Person

Patents Grantslast 30 patents

Factor IXa crystals, related complexes and methods

Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase i...

Compounds that are ERK inhibitors

MEK1 polypeptides

Kinase domain polypeptide of human protein kinase B gamma (AKT3)

Crystal of pregnane X receptor fused to steroid receptor coactivator-1

Polynucleotides encoding soluble, stable forms of human double minu...

Factor IXa crystals, related complexes and methods

HDM2 polypeptides

Compounds for the treatment of inflammatory disorders

Method for crystallizing aurora 2 kinase catalytic domain polypeptide

Compounds that are ERK inhibitors

N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pregnane X receptor compositions, crystals and uses thereof

Polynucleotides encoding polypeptide fragments of protein kinase B...

HDM2 Polypeptides

4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]p...

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Soluble, stable form of HDM2, crystalline forms thereof and methods...

Compounds for the treatment of inflammatory disorders and microbial...

Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinas...

High affinity quinoline-based kinase ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Hepatitis C virus NS3 helicase subdomain I

Crystalline form of the catalytic domain of Aurora 2 kinase and met...

Catalytic domain of ADAM33 and methods of use thereof

Patents Applicationslast 30 patents

Factor IXa Crystals, Related Complexes and Methods

Pregnane X Receptor Compositions, Crystals and Uses Thereof

HDM2 POLYPEPTIDES

AKT3 POLYPEPTIDES

NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1...

NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1...

SOLUBLE, STABLE FORM OF HDM2, CRYSTALLINE FORMS THEREOF AND METHODS...

P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Novel compounds that are ERK inhibitors

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

CRYSTALLINE FORM OF THE CATALYTIC DOMAIN OF AURORA 2 KINASE AND MET...

CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

Novel high affinity quinoline-based kinase ligands

Novel compounds that are ERK inhibitors

Compounds for the treatment of inflammatory disorders

Novel compounds that are ERK inhibitors

Compounds for the treatment of inflammatory disorders and microbial...

Compounds for the treatment of inflammatory disorders and microbial...

Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1...

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

Catalytic domain of ADAM33 and methods of use thereof

Compounds for the treatment of inflammatory disorders

Compounds for inhibiting KSP kinesin activity

Compounds for the treatment of inflammatory disorders

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors